| __timestamp | Catalyst Pharmaceuticals, Inc. | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 10117774 | 4733600000 |
| Thursday, January 1, 2015 | 11801342 | 4796400000 |
| Friday, January 1, 2016 | 11369941 | 5243900000 |
| Sunday, January 1, 2017 | 11375237 | 5281800000 |
| Monday, January 1, 2018 | 19919204 | 5051200000 |
| Tuesday, January 1, 2019 | 18842752 | 5595000000 |
| Wednesday, January 1, 2020 | 16496715 | 6085700000 |
| Friday, January 1, 2021 | 16936000 | 7025900000 |
| Saturday, January 1, 2022 | 19789000 | 7190800000 |
| Sunday, January 1, 2023 | 93150000 | 9313400000 |
| Monday, January 1, 2024 | 14271000000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, research and development (R&D) investment is a critical driver of innovation and growth. Over the past decade, Eli Lilly and Company has consistently outpaced Catalyst Pharmaceuticals, Inc. in R&D spending. From 2014 to 2023, Eli Lilly's R&D expenses surged by nearly 97%, reaching a peak of approximately $9.3 billion in 2023. This robust investment underscores Eli Lilly's commitment to pioneering new treatments and maintaining its competitive edge.
In contrast, Catalyst Pharmaceuticals, while showing a significant increase in R&D spending in 2023, with a 370% rise from its 2014 levels, still trails far behind Eli Lilly. This disparity highlights the varying scales and strategies of these two companies in the pharmaceutical sector. As the industry continues to evolve, these investments will play a pivotal role in shaping the future of healthcare.
R&D Spending Showdown: Eli Lilly and Company vs Dr. Reddy's Laboratories Limited
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Madrigal Pharmaceuticals, Inc.
Comparing Innovation Spending: Eli Lilly and Company and Opthea Limited
Comparing Innovation Spending: Eli Lilly and Company and Ionis Pharmaceuticals, Inc.
Eli Lilly and Company vs Veracyte, Inc.: Strategic Focus on R&D Spending
Eli Lilly and Company or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Gilead Sciences, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Insights: How Bio-Techne Corporation and Catalyst Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Grifols, S.A. vs Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.